US approves first new Alzheimer's drug in 20 years

  • Published
    10th Jun, 2021

GS-III: Science and Technology

  • Science and Technology- developments and their applications and effects in everyday life.
Context

Recently, U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer’s disease, a debilitating disease affecting more than 30 million people around the world.

Prelims question:

Consider the following statements:

  1. Both Alzheimer’s and Parkinson’s diseases are characterized by clumping of modified proteins in the central nervous system.
  2. Alzheimer’s disease has clumps of beta-amyloid and tau whereas, Parkinson’s disease has Lewy bodiescomposed of alpha-synuclein.
  3. The movement problems in Parkinson’s disease are due to abnormally high production of dopamine by the neurons.

Which of the above statement(s) is/are correct?

  • A.
  • B.
  • C.
  • D.

Mains Question:

What is Alzheimer’s disease? How it is different from the Parkinson’s disease? How these neurodegenerativediseases arecurrently managed in India? (250 words)

X

© 2020 Basix Education Pvt. Ltd. All Rights Reserved

Enquire Now